Garmaa G, Nagy R, Koi T, Do To U, Gergo D, Kleiner D
BMC Nephrol. 2024; 25(1):261.
PMID: 39138396
PMC: 11323638.
DOI: 10.1186/s12882-024-03702-y.
Wong Y, Mancanares A, Navarrete F, Poblete P, Mendez-Perez L, Cabezas J
Vet Q. 2024; 44(1):1-11.
PMID: 39086189
PMC: 11295685.
DOI: 10.1080/01652176.2024.2384906.
Mahajan A, Gunewardena S, Morris A, Clauss M, Dhillon N
Cells. 2024; 13(11.
PMID: 38891019
PMC: 11172129.
DOI: 10.3390/cells13110886.
Garmaa G, Bunduc S, Koi T, Hegyi P, Csupor D, Ganbat D
Noncoding RNA. 2024; 10(3).
PMID: 38804362
PMC: 11130806.
DOI: 10.3390/ncrna10030030.
Sobanski D, Bogdal P, Staszkiewicz R, Sobanska M, Filipowicz M, Czepko R
Cell Cycle. 2024; 23(5):555-572.
PMID: 38695374
PMC: 11135850.
DOI: 10.1080/15384101.2024.2345484.
Metabolic memory: mechanisms and diseases.
Dong H, Sun Y, Nie L, Cui A, Zhao P, Leung W
Signal Transduct Target Ther. 2024; 9(1):38.
PMID: 38413567
PMC: 10899265.
DOI: 10.1038/s41392-024-01755-x.
Therapeutic potential for renal fibrosis by targeting Smad3-dependent noncoding RNAs.
Gu Y, Liu X, Lan H
Mol Ther. 2023; 32(2):313-324.
PMID: 38093516
PMC: 10861968.
DOI: 10.1016/j.ymthe.2023.12.009.
Novel Approaches in Chronic Renal Failure without Renal Replacement Therapy: A Review.
Martinez-Hernandez S, Munoz-Ortega M, Avila-Blanco M, Medina-Pizano M, Ventura-Juarez J
Biomedicines. 2023; 11(10).
PMID: 37893201
PMC: 10604533.
DOI: 10.3390/biomedicines11102828.
The Role of miRNA in Renal Fibrosis Leading to Chronic Kidney Disease.
Gluba-Sagr A, Franczyk B, Rysz-Gorzynska M, Lawinski J, Rysz J
Biomedicines. 2023; 11(9).
PMID: 37760798
PMC: 10525803.
DOI: 10.3390/biomedicines11092358.
Epigenetic modification in diabetic kidney disease.
Liu Z, Liu J, Wang W, An X, Luo L, Yu D
Front Endocrinol (Lausanne). 2023; 14:1133970.
PMID: 37455912
PMC: 10348754.
DOI: 10.3389/fendo.2023.1133970.
Identification of miRnas with possible prognostic roles for HAM/TSP.
de Souza D, Pessoa R, Nukui Y, Pereira J, Marcusso R, de Oliveira A
Virulence. 2023; 14(1):2230015.
PMID: 37394816
PMC: 10321194.
DOI: 10.1080/21505594.2023.2230015.
Serum exosomal miR-192 serves as a potential detective biomarker for early pregnancy screening in sows.
Gao R, Li Q, Qiu M, Xie S, Sun X, Huang T
Anim Biosci. 2023; 36(9):1336-1349.
PMID: 37170506
PMC: 10472158.
DOI: 10.5713/ab.22.0422.
Emodin ameliorates renal injury and fibrosis regulating the miR-490-3p/HMGA2 axis.
Wang L, Wang X, Li G, Zhou S, Wang R, Long Q
Front Pharmacol. 2023; 14:1042093.
PMID: 36937888
PMC: 10020706.
DOI: 10.3389/fphar.2023.1042093.
Delivery of anti-microRNA-21 by lung-targeted liposomes for pulmonary fibrosis treatment.
Yan L, Su Y, Hsia I, Xu Y, Vincent-Chong V, Mojica W
Mol Ther Nucleic Acids. 2023; 32:36-47.
PMID: 36919116
PMC: 9972768.
DOI: 10.1016/j.omtn.2023.02.031.
Coinfection of Dermal Fibroblasts by Human Cytomegalovirus and Human Herpesvirus 6 Can Boost the Expression of Fibrosis-Associated MicroRNAs.
Soffritti I, DAccolti M, Maccari C, Bini F, Mazziga E, Arcangeletti M
Microorganisms. 2023; 11(2).
PMID: 36838377
PMC: 9958881.
DOI: 10.3390/microorganisms11020412.
VHL-recruiting PROTAC attenuates renal fibrosis and preserves renal function via simultaneous degradation of Smad3 and stabilization of HIF-2α.
Yang J, Ruan Y, Wang D, Fan J, Luo N, Chen H
Cell Biosci. 2022; 12(1):203.
PMID: 36536448
PMC: 9761961.
DOI: 10.1186/s13578-022-00936-x.
TGF-β1/Smad Signalling in Proliferative Glomerulonephritis Associated with Autoimmune Diseases.
Chalkia A, Gakiopoulou H, Theochari I, Foukas P, Vassilopoulos D, Petras D
Mediterr J Rheumatol. 2022; 33(2):176-184.
PMID: 36128207
PMC: 9450207.
DOI: 10.31138/mjr.33.2.176.
Exosomes: A novel insight into traditional Chinese medicine.
Mo C, Zhao J, Liang J, Wang H, Chen Y, Huang G
Front Pharmacol. 2022; 13:844782.
PMID: 36105201
PMC: 9465299.
DOI: 10.3389/fphar.2022.844782.
miR-29c Inhibits Renal Interstitial Fibrotic Proliferative Properties through PI3K-AKT Pathway.
Feng W, Xie H, Li J, Yan X, Zhu S, Sun S
Appl Bionics Biomech. 2022; 2022:6382323.
PMID: 36051820
PMC: 9427319.
DOI: 10.1155/2022/6382323.
Serum α-KL, a potential early marker of diabetes complications in youth with T1D, is regulated by miRNA 192.
Gong Z, Banchs P, Liu Y, Fu H, Arena V, Forno E
Front Endocrinol (Lausanne). 2022; 13:937093.
PMID: 35992154
PMC: 9388782.
DOI: 10.3389/fendo.2022.937093.